| Particulars |
| Company Name |
Kabra Drugs Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
23.71 |
B.V. Rs |
11.00 |
| Sales Rs Cr. |
0.00 |
NP Rs Cr. |
-1.09 |
| NP Var% |
-47.00 |
Div% |
0.00 |
| CPS Rs |
-0.50 |
EPS Rs |
-0.50 |
| Traded Value(Rs Lakhs) |
10.78 |
52 Week High |
36.00 |
| 52 Week Low |
11.00 |
Price BSE |
26.00 |
| Price NSE |
0.00 |
Market Capital(Rs Cr.) |
62.52 |
| P/C Ratio |
-57.20 |
P/E Ratio |
-56.80 |
| Price Vs.BV |
2.36 |
|
| Latest Quarter |
| Year End |
202512 |
Sales Rs Cr. |
30.42 |
| NP Rs Cr. |
2.57 |
NP Var % |
578.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
-1.42 |
| NP Var% |
332.28 |
EPS |
1.81 |
| PE |
14.57 |
|
|